Alten Vs. Halozyme Therapeutics Industry Stock Comparison

Sell

20

ABLGF
Alten

Last Price:

152.26

Seasonality Move:

32.4%

Sell

39

HALO
Halozyme Therapeutics

Last Price:

42.89

Seasonality Move:

17.03%

Sell

20

Alten (ABLGF) is a Sell

Is Alten a Buy, Sell or Hold?

The current Alten [ABLGF] share price is $152.26. The Score for ABLGF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
ABLGF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

39

Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABLGF Stock Price Chart

What is Alten's stock price today?

The Alten share price today is $152.26
The current trend is relatively stagnant and ABLGF is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ABLGF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0	Sell
Relative Strength Index (14 RSI):	0	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(152.26 - 152.26)	Sell
Bollinger Bands (100):	(152.26 - 152.26)	Sell

HALO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	30.2	Sell
Chaikin Money Flow:	-7140517	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(49.94 - 58.56)	Sell
Bollinger Bands (100):	(52.16 - 60.38)	Sell

ABLGF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	152.26	Sell
20-day SMA:	152.26	Sell
50-day SMA:	152.26	Sell
200-day SMA:	151.89	Buy
8-day EMA:	152.26	Sell
20-day EMA:	152.26	Sell
50-day EMA:	152.26	Sell
200-day EMA:	41.7	Buy

HALO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	57.53	Sell
20-day SMA:	54.48	Sell
50-day SMA:	56.18	Sell
200-day SMA:	48.93	Sell
8-day EMA:	55	Sell
20-day EMA:	55.41	Sell
50-day EMA:	55.64	Sell
200-day EMA:	50.73	Sell

Alten Earnings Growth & ABLGF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Alten Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):